DKK 366.2
(0.16%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 623 Million | 968 Million | 1.44 Billion | 1.42 Billion | 948 Million | 385 Million |
Net Income | 1.59 Billion | 1.29 Billion | 1.32 Billion | 1.11 Billion | 1.98 Billion | 1.66 Billion |
Depreciation & Amortization | 499 Million | 681 Million | 676 Million | 682 Million | 722 Million | 604 Million |
Deferred income taxes | -54 Million | -25 Million | -691 Million | -661 Million | -735 Million | - |
Stock-based compensation | 54 Million | 25 Million | 15 Million | -21 Million | 13 Million | 45 Million |
Change in working capital | 175 Million | 392 Million | 923 Million | 799 Million | -698 Million | -788 Million |
Other non-cash items | -1.64 Billion | -1.39 Billion | -800 Million | -497 Million | -343 Million | -1.09 Billion |
Investing Cash Flow | -257 Million | -2.31 Billion | -273 Million | -376 Million | -661 Million | -285 Million |
Investments in PPE | -499 Million | -333 Million | -295 Million | -349 Million | -419 Million | -508 Million |
Acquisitions | 165 Million | -2.11 Billion | -9 Million | -37 Million | -287 Million | 115 Million |
Investment purchases | -3 Million | -23 Million | -8 Million | -7 Million | -2 Million | -19 Million |
Sales/Maturities of investments | 323 Million | 6 Million | 179 Million | 7 Million | 242 Million | 47 Million |
Other Investing Activities | -243 Million | 159 Million | -140 Million | 10 Million | -195 Million | 80 Million |
Financing Cash Flow | -1.06 Billion | 1.59 Billion | -276 Million | -956 Million | -156 Million | -578 Million |
Debt repayment | -749 Million | -1.9 Billion | -1.53 Billion | -822 Million | -1.96 Billion | -250 Million |
Dividends payments | -170 Million | -176 Million | -101 Million | -14 Million | -450 Million | -421 Million |
Common Stock Repurchased | -1 Million | - | -125 Million | - | 2.23 Billion | -40 Million |
Common Stock Issuance | 749 Million | - | 1.47 Billion | - | 21 Million | 133 Million |
Other Financing Activities | -895 Million | 3.67 Billion | 3 Million | -120 Million | 7 Million | -250 Million |
Accounts receivables | 431 Million | 92 Million | -547 Million | 1.24 Billion | -392 Million | -359 Million |
Accounts payables | -208 Million | 379 Million | 216 Million | -1.05 Billion | 633 Million | 340 Million |
Inventory | 310 Million | -680 Million | 10 Million | 143 Million | 57 Million | -336 Million |
Other working capital | -358 Million | 601 Million | 1.24 Billion | 466 Million | -996 Million | -452 Million |
Cash at beginning of period | 2.13 Billion | 1.93 Billion | 976 Million | 1 Billion | 875 Million | 1.42 Billion |
Cash at end of period | 1.35 Billion | 2.13 Billion | 1.93 Billion | 976 Million | 1 Billion | 875 Million |
Capital Expenditure | -499 Million | -333 Million | -295 Million | -349 Million | -419 Million | -508 Million |
Effect of forex changes on cash | -78 Million | -59 Million | 59 Million | -114 Million | -5 Million | -72 Million |
Net cash flow / Change in cash | -778 Million | 195 Million | 959 Million | -25 Million | 126 Million | -550 Million |
Free Cash Flow | 124 Million | 635 Million | 1.15 Billion | 1.07 Billion | 529 Million | -123 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 181 Million | 194 Million | 1.59 Billion | 329 Million | 537 Million | 411 Million |
Depreciation & Amortization | 129 Million | 137 Million | 499 Million | 134 Million | 134 Million | 148 Million |
Deferred income taxes | - | - | -54 Million | -54 Million | - | - |
Stock-based compensation | - | - | 54 Million | 54 Million | - | - |
Change in working capital | -276 Million | -530 Million | 175 Million | 828 Million | -539 Million | 236 Million |
Other non-cash items | 238 Million | 121 Million | -1.64 Billion | -360 Million | -408 Million | -423 Million |
Investing Cash Flow | -103 Million | 46 Million | -257 Million | -204 Million | 125 Million | -154 Million |
Investments in PPE | -162 Million | -100 Million | -499 Million | -157 Million | -164 Million | -111 Million |
Acquisitions | 60 Million | 148 Million | 165 Million | -78 Million | 285 Million | -42 Million |
Investment purchases | -1 Million | -2 Million | -3 Million | 115 Million | -1 Million | -2 Million |
Sales/Maturities of investments | - | - | 323 Million | -1 Million | 88 Million | 77 Million |
Other Investing Activities | -23 Million | 197 Million | -243 Million | -83 Million | -83 Million | -76 Million |
Financing Cash Flow | 42 Million | 513 Million | -1.06 Billion | -854 Million | -113 Million | -180 Million |
Debt repayment | -309 Million | -541 Million | -749 Million | -817 Million | -83 Million | -41 Million |
Dividends payments | -227 Million | - | -170 Million | - | - | -170 Million |
Common Stock Repurchased | -19 Million | - | -1 Million | -1 Million | -1 Million | - |
Common Stock Issuance | - | - | 749 Million | 1 Million | -1 Million | - |
Other Financing Activities | -21 Million | - | -895 Million | -37 Million | -28 Million | 31 Million |
Accounts receivables | - | - | 431 Million | 431 Million | - | - |
Accounts payables | - | - | -208 Million | -741 Million | - | - |
Inventory | - | - | 310 Million | 310 Million | - | - |
Other working capital | -276 Million | -530 Million | -358 Million | 828 Million | -539 Million | 236 Million |
Cash at beginning of period | 1.56 Billion | 1.35 Billion | 2.13 Billion | 1.51 Billion | 1.75 Billion | 1.75 Billion |
Cash at end of period | 1.51 Billion | 1.56 Billion | 1.35 Billion | 1.35 Billion | 1.51 Billion | 1.75 Billion |
Capital Expenditure | -162 Million | -100 Million | -499 Million | -157 Million | -164 Million | -111 Million |
Effect of forex changes on cash | -1 Million | 1 Million | -78 Million | -31 Million | 20 Million | -41 Million |
Net cash flow / Change in cash | -48 Million | 208 Million | -778 Million | -158 Million | -244 Million | -3 Million |
Free Cash Flow | -148 Million | -452 Million | 124 Million | 774 Million | -440 Million | 261 Million |
020760
B28
INNX
BROE
0F2Z
ATOM